DNA synthesis market to hit $30.4b by 2035 on rising gene-editing demand

It is also driven by gene therapy expansion.

The DNA synthesis market is estimated to reach $30.4b by 2035, growing at a compound annual growth rate (CAGR) of 18.2% from 2026 to 2035, according to an Allied Market Research report.

One of the primary drivers is the rapid advancement of gene-editing technologies, such as CRISPR-Cas systems, which require custom-designed DNA sequences.

Additionally, it is also being fuelled by the expansion of gene therapy and personalised medicine.

Despite strong growth prospects, high capital investment requirements, reagents, and GMP-compliant manufacturing infrastructure limit entry for small and mid-sized players.

Also, technical limitations, such as increasing error rates and challenges in synthesising complex genetic structures, restrict scalability.

On a regional basis, the Asia-Pacific is expected to register the highest CAGR due to biotechnology research, government support, and growing outsourcing activities.